Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model

The emergence of SARS-CoV-2 variants of concern (VoCs) has exacerbated the COVID-19 pandemic. Currently available monoclonal antibodies and vaccines appear to have reduced efficacy against some of these VoCs. Antivirals targeting conserved proteins of SARS-CoV-2 are unlikely to be affected by mutati...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelnabi, Rana, Foo, Caroline S, De Jonghe, Steven, Maes, Piet, Weynand, Birgit, Neyts, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408768/
https://www.ncbi.nlm.nih.gov/pubmed/34244768
http://dx.doi.org/10.1093/infdis/jiab361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408768/
https://www.ncbi.nlm.nih.gov/pubmed/34244768
http://dx.doi.org/10.1093/infdis/jiab361

Ejemplares similares